IRS1 and Alzheimer disease: In our study, we observed alterations in IRS-1 phosphorylation, characterized by increased phosphorylation at Ser307 and decreased phosphorylation at Tyr895 in 3xTg AD mice and oTau-treated CECs, indicating a shift toward disruption of insulin signaling.